| Literature DB >> 27580810 |
Cecilia Ratner1, Louise J Skov1, Zindy Raida1, Thomas Bächler1, Kathrin Bellmann-Sickert1, Christelle Le Foll1, Bjørn Sivertsen1, Louise S Dalbøge1, Bolette Hartmann1, Annette G Beck-Sickinger1, Andreas N Madsen1, Jacob Jelsing1, Jens J Holst1, Thomas A Lutz1, Zane B Andrews1, Birgitte Holst1.
Abstract
Neurotensin (NT) is a peptide expressed in the brain and in the gastrointestinal tract. Brain NT inhibits food intake, but the effects of peripheral NT are less investigated. In this study, peripheral NT decreased food intake in both mice and rats, which was abolished by a NT antagonist. Using c-Fos immunohistochemistry, we found that peripheral NT activated brainstem and hypothalamic regions. The anorexigenic effect of NT was preserved in vagotomized mice but lasted shorter than in sham-operated mice. This in combination with a strong increase in c-Fos activation in area postrema after ip administration indicates that NT acts both through the blood circulation and the vagus. To improve the pharmacokinetics of NT, we developed a pegylated NT peptide, which presumably prolonged the half-life, and thus, the effect on feeding was extended compared with native NT. On a molecular level, the pegylated NT peptide increased proopiomelanocortin mRNA in the arcuate nucleus. We also investigated the importance of NT for the decreased food intake after gastric bypass surgery in a rat model of Roux-en-Y gastric bypass (RYGB). NT was increased in plasma and in the gastrointestinal tract in RYGB rats, and pharmacological antagonism of NT increased food intake transiently in RYGB rats. Taken together, our data suggest that NT is a metabolically active hormone, which contributes to the regulation of food intake.Entities:
Mesh：
Substances：
Year: 2016 PMID： 27580810 DOI： 10.1210/en.2016-1329
Source DB: PubMed Journal: Endocrinology ISSN： 0013-7227 Impact factor: 4.736